Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yi Larson currently holds 29,500 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yi Larson has been a net seller of TPTX stock. They have purchased $100.0K and sold $3.8M worth of shares.
Yi Larson's most recent insider trade was on Jun 18, 2026, when they sold 29,500 shares at $0.00 per share.
Yi Larson serves as Executive at Turning Point Therapeutics, Inc. (TPTX). They have executed 19 insider transactions totaling $3.9M over their tenure at the company.
Yi Larson holds the position of Executive at Turning Point Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Yi Larson has shown a selling trading pattern, with $100.0K in total purchases and $3.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Yi Larson was on Feb 1, 2021, when they sold $1.1M worth of TPTX shares. This transaction involved 8,576 shares at $123.70 per share.
Yi Larson currently owns 29,500 shares of Turning Point Therapeutics, Inc. (TPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yi Larson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yi Larson has 19 Form 4 filings on record as an insider at Turning Point Therapeutics, Inc..
Set alerts for Yi Larson and 40,000+ other insiders.